JP2020517658A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517658A5 JP2020517658A5 JP2019557434A JP2019557434A JP2020517658A5 JP 2020517658 A5 JP2020517658 A5 JP 2020517658A5 JP 2019557434 A JP2019557434 A JP 2019557434A JP 2019557434 A JP2019557434 A JP 2019557434A JP 2020517658 A5 JP2020517658 A5 JP 2020517658A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- antibody
- cancer
- ecm
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024001630A JP2024041874A (ja) | 2017-04-20 | 2024-01-10 | 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762487823P | 2017-04-20 | 2017-04-20 | |
| US62/487,823 | 2017-04-20 | ||
| PCT/US2018/028505 WO2018195386A1 (en) | 2017-04-20 | 2018-04-20 | Methods and compositions for treating cancer with ecm-affinity peptides linked to immunotherapeutic antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024001630A Division JP2024041874A (ja) | 2017-04-20 | 2024-01-10 | 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020517658A JP2020517658A (ja) | 2020-06-18 |
| JP2020517658A5 true JP2020517658A5 (enExample) | 2021-05-27 |
| JP7419070B2 JP7419070B2 (ja) | 2024-01-22 |
Family
ID=63856403
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019557434A Active JP7419070B2 (ja) | 2017-04-20 | 2018-04-20 | 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物 |
| JP2024001630A Pending JP2024041874A (ja) | 2017-04-20 | 2024-01-10 | 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024001630A Pending JP2024041874A (ja) | 2017-04-20 | 2024-01-10 | 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11574747B2 (enExample) |
| EP (1) | EP3612209A4 (enExample) |
| JP (2) | JP7419070B2 (enExample) |
| CN (1) | CN111132693A (enExample) |
| AU (2) | AU2018256453B2 (enExample) |
| MX (1) | MX2019012579A (enExample) |
| WO (1) | WO2018195386A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108623686A (zh) | 2017-03-25 | 2018-10-09 | 信达生物制药(苏州)有限公司 | 抗ox40抗体及其用途 |
| AU2018256453B2 (en) * | 2017-04-20 | 2024-02-08 | The University Of Chicago | Methods and compositions for treating cancer with ECM-affinity peptides linked to immunotherapeutic antibodies |
| US11732029B2 (en) | 2017-11-13 | 2023-08-22 | The University Chicago | Methods and compositions for the treatment of wounds |
| CN112292391A (zh) | 2018-03-05 | 2021-01-29 | 芝加哥大学 | 用与细胞因子连接的ecm亲和肽治疗癌症的方法和组合物 |
| CA3105454A1 (en) | 2018-07-03 | 2020-01-09 | Catalent Pharma Solutions, Llc | Multifunctional protein molecules comprising decorin and use thereof |
| EP3930687A4 (en) * | 2019-02-25 | 2023-06-07 | The University of Chicago | METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS USING ECM AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS |
| CN114206355A (zh) * | 2019-06-03 | 2022-03-18 | 芝加哥大学 | 用靶向癌症的佐剂治疗癌症的方法和组合物 |
| EP4076669A4 (en) * | 2019-12-19 | 2024-01-10 | Board of Regents, The University of Texas System | METHOD FOR TREATING GLIOBLASTOMA |
| CN115065734A (zh) * | 2021-02-27 | 2022-09-16 | 华为技术有限公司 | 一种数据处理方法、装置及芯片 |
| WO2025203029A1 (en) * | 2024-03-28 | 2025-10-02 | Hadasit Medical Research Services And Development Ltd. | Tricer - a tri-specific cell engager and retainer |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5086620A (en) | 1991-02-14 | 1992-02-11 | Wayne State University | Method of microencapsulation of hyperbaric gas |
| US5654270A (en) | 1988-06-28 | 1997-08-05 | La Jolla Cancer Research Foundation | Use of fibromodulin to prevent or reduce dermal scarring |
| FR2707658B1 (fr) | 1993-07-12 | 1995-11-24 | Prolabo Sa | Latex fluorescent comportant au moins deux fluorochromes, procédé d'obtention et application dudit latex comme marqueur, notamment en biologie. |
| US5830430A (en) | 1995-02-21 | 1998-11-03 | Imarx Pharmaceutical Corp. | Cationic lipids and the use thereof |
| US6033645A (en) | 1996-06-19 | 2000-03-07 | Unger; Evan C. | Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
| GB9712525D0 (en) | 1997-06-16 | 1997-08-20 | Nycomed Imaging As | Method |
| US6106474A (en) | 1997-11-19 | 2000-08-22 | Scimed Life Systems, Inc. | Aerogel backed ultrasound transducer |
| US6123923A (en) | 1997-12-18 | 2000-09-26 | Imarx Pharmaceutical Corp. | Optoacoustic contrast agents and methods for their use |
| WO2001016180A2 (en) * | 1999-08-27 | 2001-03-08 | Board Of Regents, The University Of Texas System | Cd40 agonist compositions and methods of use |
| US6626855B1 (en) | 1999-11-26 | 2003-09-30 | Therus Corpoation | Controlled high efficiency lesion formation using high intensity ultrasound |
| JP5074652B2 (ja) | 2000-02-08 | 2012-11-14 | ライスユニバーシティ | 治療法および診断法において使用される光学活性なナノ粒子 |
| CA2406133A1 (en) | 2000-04-17 | 2001-10-25 | Rashid Bashir | Biosensor and related method |
| JP2003532681A (ja) | 2000-05-05 | 2003-11-05 | ジーティーシー バイオセラピューティックス インコーポレイテッド | 遺伝子導入により産生されたデコリン |
| KR100396695B1 (ko) | 2000-11-01 | 2003-09-02 | 엘지.필립스 엘시디 주식회사 | 에천트 및 이를 이용한 전자기기용 기판의 제조방법 |
| US6939721B2 (en) | 2000-12-18 | 2005-09-06 | Agilent Technologies, Inc. | Fluorescence immunoassays using organo-metallic complexes for energy transfer |
| EP1379284A4 (en) | 2001-01-05 | 2007-07-25 | Gen Hospital | ACTIVE IMAGING PROBES |
| DE10111458B4 (de) | 2001-03-09 | 2008-09-11 | Siemens Ag | Analyseeinrichtung |
| DE10111457B4 (de) | 2001-03-09 | 2006-12-14 | Siemens Ag | Diagnoseeinrichtung |
| DE10137530A1 (de) | 2001-08-01 | 2003-02-13 | Presens Prec Sensing Gmbh | Anordnung und Verfahren zur Mehrfach-Fluoreszenzmessung |
| US20030104512A1 (en) | 2001-11-30 | 2003-06-05 | Freeman Alex R. | Biosensors for single cell and multi cell analysis |
| US6806543B2 (en) | 2002-09-12 | 2004-10-19 | Intel Corporation | Microfluidic apparatus with integrated porous-substrate/sensor for real-time (bio)chemical molecule detection |
| US20050107694A1 (en) | 2003-11-17 | 2005-05-19 | Jansen Floribertus H. | Method and system for ultrasonic tagging of fluorescence |
| US20080160024A1 (en) * | 2006-12-07 | 2008-07-03 | Board Of Trustees Of The University Of Arkansas | Inhibition of cancer metastasis |
| AT504685B1 (de) | 2006-12-20 | 2009-01-15 | Protaffin Biotechnologie Ag | Fusionsproteine |
| RU2579977C2 (ru) * | 2009-11-13 | 2016-04-10 | Грифольс Терапьютикс Инк. | СОДЕРЖАЩИЕ ФАКТОР ФОН ВИЛЛЕБРАНДА (vWF) ПРЕПАРАТЫ И СПОСОБЫ, НАБОРЫ И ПРИМЕНЕНИЯ, СВЯЗАННЫЕ С НИМИ |
| US9879062B2 (en) | 2012-07-03 | 2018-01-30 | Ecole Polytechnique Federale De Lausanne | Protein-binding peptide isolated from placenta growth factor |
| US10420820B2 (en) | 2014-09-29 | 2019-09-24 | Counterpoint Biomedia LLC | Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides |
| KR20170066546A (ko) | 2014-10-03 | 2017-06-14 | 노파르티스 아게 | 조합 요법 |
| MX2017016844A (es) | 2015-07-16 | 2018-08-15 | Biokine Therapeutics Ltd | Composiciones y procedimientos para tratar cancer. |
| EP3356371A4 (en) | 2015-09-29 | 2020-06-24 | The University of Chicago | POLYMER CONJUGATE VACCINE |
| WO2017190074A1 (en) | 2016-04-28 | 2017-11-02 | The University Of Chicago | Lymphangiogenesis for therapeutic immunomodulation |
| AU2018256453B2 (en) | 2017-04-20 | 2024-02-08 | The University Of Chicago | Methods and compositions for treating cancer with ECM-affinity peptides linked to immunotherapeutic antibodies |
| US11732029B2 (en) | 2017-11-13 | 2023-08-22 | The University Chicago | Methods and compositions for the treatment of wounds |
-
2018
- 2018-04-20 AU AU2018256453A patent/AU2018256453B2/en active Active
- 2018-04-20 US US16/606,539 patent/US11574747B2/en active Active
- 2018-04-20 JP JP2019557434A patent/JP7419070B2/ja active Active
- 2018-04-20 CN CN201880041832.4A patent/CN111132693A/zh active Pending
- 2018-04-20 EP EP18787963.0A patent/EP3612209A4/en active Pending
- 2018-04-20 WO PCT/US2018/028505 patent/WO2018195386A1/en not_active Ceased
- 2018-04-20 MX MX2019012579A patent/MX2019012579A/es unknown
-
2023
- 2023-02-03 US US18/164,164 patent/US12706227B2/en active Active
-
2024
- 2024-01-10 JP JP2024001630A patent/JP2024041874A/ja active Pending
- 2024-05-02 AU AU2024202918A patent/AU2024202918A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hou et al. | Navigating CAR-T cells through the solid-tumour microenvironment | |
| Balza et al. | Targeted Delivery of Tumor Necrosis Factor-α to Tumor Vessels Induces a Therapeutic T Cell–Mediated Immune Response that Protects the Host Against Syngeneic Tumors of Different Histologic Origin | |
| Fallon et al. | The immunocytokine NHS-IL12 as a potential cancer therapeutic | |
| JP6858558B2 (ja) | 新生物疾患の処置、減少、阻害、又は制御において使用するための、免疫調節薬 | |
| JP2023524530A (ja) | 免疫原性が低い癌の癌細胞死滅を増強するための３剤併用療法 | |
| JP2021514661A5 (enExample) | ||
| EP3328363A1 (en) | Compositions and methods for immunomodulation | |
| JP2016527286A5 (enExample) | ||
| US20220008515A1 (en) | Method of treating a tumor with a combination of il-7 protein and an immune checkpoint inhibitor | |
| JP6892443B2 (ja) | がん治療で使用するためのチェックポイント阻害剤及び全細胞マイコバクテリウム | |
| JP2019526578A (ja) | キャリアー−ｐｄ−ｌ１結合剤組成物及び癌を処置する為にそれを使用する方法 | |
| Dianat-Moghadam et al. | Immunotherapies targeting tumor vasculature: challenges and opportunities | |
| JP7139293B2 (ja) | Ｇｄ２陽性がんを処置するための製剤および方法 | |
| JP2020521478A5 (enExample) | ||
| CN103536917B (zh) | 干扰素在治疗肿瘤中的用途及相关的产品和方法 | |
| US20220249621A1 (en) | TREATMENT OF CANCERS USING sEphB4-HSA FUSION PROTEINS | |
| EP4041282A1 (en) | Methods of using il-33 protein in treating cancers | |
| EP4319751A1 (en) | Therapeutic compositions and methods for treating tumors | |
| WO2020243603A1 (en) | Dosing of bispecific t cell engager | |
| US20240216554A1 (en) | Radioimmunoconjugates directed to nkg2d ligands for the treatment of cancer | |
| US11419894B2 (en) | Modified natural killer cells for the treatment of cancer | |
| TWI812820B (zh) | 使用先天性免疫修飾劑及ox40促效劑治療疾病之組合療法 | |
| KR20170090406A (ko) | 펩타이드-단백질 콘주게이트를 이용한 종양의 치료 | |
| US20210130456A1 (en) | Single-chain variable fragment of met monoclonal antibody and methods of use in car t cell therapy | |
| CN102935228B (zh) | 用于肿瘤治疗的试剂、其用途及方法 |